Also, NFL levels are significantly reduced in patients with AMS following autologous hematopoietic stem cell transplantation in parallel with amelioration of clinical and neuroimaging features of the disease [5]. This evidence concerns the gene NEFL and ablepharon macrostomia syndrome.